{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:32:26Z","timestamp":1682325146959},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Clin Biochem"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/bf02872406","type":"journal-article","created":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T01:30:28Z","timestamp":1207963828000},"page":"122-128","source":"Crossref","is-referenced-by-count":1,"title":["Recent insights on biochemical and molecular basis for developing antihaemostatic agents: A review"],"prefix":"10.1007","volume":"19","author":[{"given":"Rahat","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Kalhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. K.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02872406_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/bi00107a001","volume":"30","author":"E.W. Davie","year":"1991","unstructured":"Davie, E.W., Fujikawa, K. and Kisiel, W. (1991) The coagulation cascade, initiation, maintenance, and regulation. Biochemistry 30, 363\u201370.","journal-title":"Biochemistry"},{"key":"BF02872406_CR2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.med.46.1.103","volume":"46","author":"G.J. Broze","year":"1995","unstructured":"Broze, Jr. G.J. (1995) Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46, 103\u201312","journal-title":"Annu. Rev. Med."},{"key":"BF02872406_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00129784-200202040-00002","volume":"2","author":"P. Thiagarajan","year":"2002","unstructured":"Thiagarajan, P. (2002) New targets for Antithrombotic drugs. Am. J. Cardiovasc. Drugs 2, 227\u201335.","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"BF02872406_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-4838(99)00266-6","volume":"1477","author":"C.T. Esmon","year":"2000","unstructured":"Esmon, C.T. (2000) Regulation of blood coagulation. Biochim. Biophys. Acta 1477, 349\u201360.","journal-title":"Biochim. Biophys. Acta"},{"key":"BF02872406_CR5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0037-1615854","volume":"82","author":"R.K. Andrews","year":"1999","unstructured":"Andrews, R.K., Shen, Y. and Aardiner, E.E.et al. (1999) The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb. Haemost. 82, 357\u201364.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0165-6147(00)01759-4","volume":"22","author":"E.A. Barnard","year":"2000","unstructured":"Barnard, E.A. and Simon, I. (2000) An elusive receptor is finally caught. P2Y12, an important drug target in platelets. Trends Pharmacol. Sci. 22, 388\u201391.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF02872406_CR7","first-page":"1029","volume":"18","author":"A.D. Blann","year":"2003","unstructured":"Blann, A.D., Landry, J.M. and Lip, G.Y.H. (2003) ABC of Antithrombotic therapy. An over view of Antithrombotic therapy. B.M.J. (South Asia Ed) 18, 1029\u201332.","journal-title":"B.M.J. (South Asia Ed)"},{"key":"BF02872406_CR8","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.96.4.1299","volume":"96","author":"H. Matsuno","year":"1997","unstructured":"Matsuno, H., Kozawa, O. and Niwa, M.et al. (1997) Inhibition of von Willebrand factor binding to platelet ap Ib by a fractionated a urin tricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery Circulation 96, 1299\u2013304.","journal-title":"Circulation"},{"key":"BF02872406_CR9","doi-asserted-by":"crossref","unstructured":"Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2\/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT) Circulation 1997; 89, 588\u201395.","DOI":"10.1161\/01.CIR.89.2.588"},{"key":"BF02872406_CR10","first-page":"236","volume":"6","author":"N. Hatori","year":"2000","unstructured":"Hatori, N., Takeshima, S., Aoki, T.et al. (2000) Effectiveness of prostaglandin E1 on pulmonary hypertension and right cardiac function induced by single-lung ventilation and hypoventilation. Ann. Thorac. Cardiovasc. Surg. 6, 236\u201341.","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"BF02872406_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0037-1616241","volume":"86","author":"B.S. Coller","year":"2001","unstructured":"Coller, B.S. (2001) Anti-apIIb\/IIIa drugs. current strategies and future directions. Thromb. Haemost. 86, 427\u201343.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0735-1097(01)01423-1","volume":"38","author":"J.C. Blankenship","year":"2001","unstructured":"Blankenship, J.C., Tasissa, A. and O\u2019Shea, J.C.et al. (2001) Effect of glycoprotein IIb\/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. J. Am. Coll. Cardiol. 38, 653\u20138.","journal-title":"J. Am. Coll. Cardiol."},{"key":"BF02872406_CR13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","volume":"344","author":"E.I. Topnl","year":"2001","unstructured":"Topnl, E.I., Moliterno, D.I. and Hermann, H.C.et al. (2001) Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N. Engl. J. Med. 344, 1888\u201394.","journal-title":"N. Engl. J. Med."},{"key":"BF02872406_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4615-5391-5_6","volume":"425","author":"D.L. Becker","year":"1997","unstructured":"Becker, D.L., Fredenburgh, J.C. and Stafford, A.R.,et al. (1997) Molecular basis for the resistance of fibrin-bound thrombin to inactivation by hepariniserpin complexes Adv. Exp. Med. Biol. 425, 55\u201366.","journal-title":"Adv. Exp. Med. Biol."},{"key":"BF02872406_CR15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.103.10.1479","volume":"103","author":"A. Greinacher","year":"2001","unstructured":"Greinacher, A. and Lubenow, N. (2001) Recombinant hirudin in clinical practice: focus on 46 lepirudin. Circulation 103, 1479\u201384.","journal-title":"Circulation"},{"key":"BF02872406_CR16","first-page":"F27","volume":"12","author":"S.M. Bates","year":"2000","unstructured":"Bates, S.M. and Weitz, J.I. (2000) The mechanism of action of thrombin inhibitors. J. Invasive Cardiol. 12, F27\u201332.","journal-title":"J. Invasive Cardiol."},{"key":"BF02872406_CR17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0889-8588(18)30299-5","volume":"6","author":"J.W. Fenton","year":"1992","unstructured":"Fenton, J.W. (1992) Leeches to hirulogs and other thrombin-directed antithrombotics. Hematol. Oncol. Clin. N. Am. 6, 1121\u201348.","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"BF02872406_CR18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/13543784.9.5.1119","volume":"9","author":"R. Scatena","year":"2000","unstructured":"Scatena, R. (2000) Bivalirudin: a new generation antithrombotic drug. Expert Opin. Investig. Drugs 9, 1119\u201327.","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BF02872406_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-200161040-00005","volume":"61","author":"K. McKeage","year":"2001","unstructured":"McKeage, K. and Plosker, G.L. (2001) Argatroban, Drugs 61, 515\u201322.","journal-title":"Drugs"},{"key":"BF02872406_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1026591023462","volume":"10","author":"F. Vermeer","year":"2000","unstructured":"Vermeer, F., Vahanian, A. and Fels, P.W.et al. (2000) Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI Study. J. Thromb. Thrombolysis 10, 233\u201340.","journal-title":"J. Thromb. Thrombolysis"},{"key":"BF02872406_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-0037-1614477","volume":"81","author":"H. Eriksson","year":"1999","unstructured":"Eriksson, H., Eriksson, U.G. and Frison, L.et al. (1999) Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT. Thromb. Haemost. 81, 358\u201363.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0037-1612989","volume":"87","author":"B.I. Eriksson","year":"2002","unstructured":"Eriksson, B.I., Arfwidsson, A.C. and Frison, L.,et al. (2002) A dose-ranging study of the oral direct thrombin inhibition in Orthopaedic surgery. Thromb. Haemost. 87, 231\u20137.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2007-1002730","volume":"15","author":"J. Choay","year":"1989","unstructured":"Choay, J. (1989) Structure and activity of heparin and its fragments: an overview. Semin. Thromb. Hemost. 15, 359\u201364.","journal-title":"Semin. Thromb. Hemost."},{"key":"BF02872406_CR24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2165\/00003495-199754060-00008","volume":"54","author":"M.I. Wilde","year":"1997","unstructured":"Wilde, M.I. and Markham, A. (1997) Danaparoid: a review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs 54, 903\u201324.","journal-title":"Drugs"},{"key":"BF02872406_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001721-199601000-00005","volume":"7","author":"F.A. Nicolini","year":"1996","unstructured":"Nicolini, F.A., Lee, P. and Malycky, I.L.et al. (1996) Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis. Blood Coagul. Fibrinolysis 7, 39\u201348.","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"BF02872406_CR26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM200103013440901","volume":"344","author":"A.G. Turpie","year":"2001","unstructured":"Turpie, A.G., Gallus, A.S. and Hoek, J.A. (2001) A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N. Engl. J. Med. 344, 619\u201325.","journal-title":"N. Engl. J. Med."},{"key":"BF02872406_CR27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0037-1615593","volume":"85","author":"L. Presta","year":"2001","unstructured":"Presta, L., Sims, P. and Meng, Y.G.et al. (2001) Generation of a humanized, high affinity antitissue factor antibody for use as a novel antithrombotic therapeutic. Thromb. Haemost. 85, 379\u201389.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0037-1615608","volume":"85","author":"J. Himber","year":"2001","unstructured":"Himber, J., Refino, C.J. and Burcklen, L.et al. (2001) Inhibition of arterial thrombosis by a soluble tissue factor mutant and active siteblocked factors IXa and Xa in the guinea pig. Thromb. Haemost. 85, 475\u201381.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1642658","volume":"74","author":"G.J. Broze","year":"1995","unstructured":"Broze, Jr. G.J. (1995) Tissue factor pathway inhibitor. Thromb. Haemost. 74, 90\u20133.","journal-title":"Thromb. Haemost."},{"key":"BF02872406_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2165\/00003495-198700333-00013","volume":"33","author":"B. Nunn","year":"1987","unstructured":"Nunn, B., Esmail, A. and Fears, R.et al. (1987) Pharmacokinetic properties of anisolated plasminogen streptokinase activator complex and other thombolytic agents in animals and in humans. Drugs 33, 88\u201392.","journal-title":"Drugs"},{"key":"BF02872406_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-198734010-00002","volume":"34","author":"J.P. Monk","year":"1987","unstructured":"Monk, J.P. and Heel, R.C. (1987) An isolated plasminogen streptokinase activator complex (APSAC): A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction, Drugs 34, 25\u201349.","journal-title":"Drugs"},{"key":"BF02872406_CR32","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","volume":"257","author":"M. Holyerts","year":"1982","unstructured":"Holyerts, M., Rijken, D.C. and Liznen, H.R.et al. (1982) Kinetics of activation of plasminogen activator. Role of fibrin. J. Biol. Chem. 257, 2912\u20139.","journal-title":"J. Biol. Chem."}],"container-title":["Indian Journal of Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02872406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02872406\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02872406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T23:53:50Z","timestamp":1631058830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02872406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF02872406"],"URL":"https:\/\/doi.org\/10.1007\/bf02872406","relation":{},"ISSN":["0970-1915","0974-0422"],"issn-type":[{"value":"0970-1915","type":"print"},{"value":"0974-0422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}